
Germany · Medical devices startup
AdjuCor GmbH is a Munich-based medical device company focused on developing innovative heart assist devices for patients with advanced heart failure.
Funding reportedLast round: Grant
AdjuCor GmbH is a Munich-based medical device company focused on developing innovative heart assist devices for patients with advanced heart failure.
Founded in 2012 by Prof. Dr. med. Stephen Wildhirt, the company is known for its flagship product, reBEAT, which is the world's first non-blood-contacting heart assist device. This unique technology provides mechanical circulatory support without direct blood contact, reducing the risks of infection and clotting associated with traditional devices. The reBEAT system is designed to be patient-specific, utilizing CT images to create implants that adapt to individual heart geometries. It features a pneumatically driven implant that synchronizes with the patient's heartbeat to support one or both ventricles. AdjuCor collaborates with leading cardiac surgery clinics to advance clinical trials and improve the quality of life for patients with severe cardiac insufficiency. The company also offers development services, including conceptual design, engineering, and personalized medicine solutions in cardiac care.
Funding, as reported
From AdjuCor GmbH's own website: 1 founder, 2 on the team.
AdvisersDr. Hamman de Vaal
What they build
Known for
heart failure managementhospital & health carehealthcare equipment & supplieshealth careclinical investigationspulsatile circulatory supportmedical equipment and supplies manufacturingheart failuremedicalinnovative cardiac supportepicardial supportcardiovascular devicesadvanced heart failure treatmenthealthcarecardiovascular device designfirst-in-human heart device
Built with from their website
YoastYoast SEOGravatarWP RocketMicrosoft Email ProvidersPriority HintsGoogle Font APIVimeoOpen GraphWordPress.org
Microsoft ExchangejQueryPRWebBabelMicrosoft 365RSSSwiperPython
Add your raise, your deck and your story, and put AdjuCor GmbH in front of investors. Or tell us what we have wrong.